Related Experiment Videos
Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder
The American Journal of Psychiatry
|October 1, 1984
Abstract:
Obsessive-compulsive patients with symptoms resistant to clomipramine were treated by lithium or L-tryptophan augmentation. The improvement noted supports the hypothesis that increasing serotonergic neurotransmission ameliorates obsessive symptoms.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Gamma knife capsulotomy for intractable OCD: Neuroimage analysis of lesion size, location, and clinical response.
Translational psychiatry·2023
A Case of HPV-Associated Oropharyngeal Squamous Cell Carcinoma with Block-Like, Partial Loss of p16 Expression.
Head and neck pathology·2022
Polygenic risk score and heritability estimates reveals a genetic relationship between ASD and OCD.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2017
Dependent personality, separation anxiety disorder and other anxiety disorders in OCD.
Personality and mental health·2015
Whole-genome association analysis of treatment response in obsessive-compulsive disorder.
Molecular psychiatry·2015
Craniosynostosis and risk factors related to thyroid dysfunction.
American journal of medical genetics. Part A·2015
Youth Autistic Traits and Brain Activation States During Socioemotional Processing.
The American journal of psychiatry·2026
Schizophrenia Beyond Genome-Wide Association Studies: It's About Time.
The American journal of psychiatry·2026
Determinants of Nonspecific Response to Treatment in Randomized Controlled Trials of Major Depressive Disorder: A Narrative Review.
The American journal of psychiatry·2026
Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial.
The American journal of psychiatry·2026
Global Prevalence of Obsessive-Compulsive and Related Disorders: A Systematic Review and Modeling Study.
The American journal of psychiatry·2026
Development of discriminatory and biopredictive bicarbonate buffer based dissolution method to screen delayed release formulations.
Drug development and industrial pharmacy·2026
Span60/Cholesterol Niosomal Formulation as a Transport Vehicle for L-DOPA and Rasagiline Delivery with Potent In Vitro Neuroprotective Effect.
Applied biochemistry and biotechnology·2026
Evaluating Powder Deposition in the Nasal Airways Using a Facile Fluorescent-Imaging Method.
Journal of aerosol medicine and pulmonary drug delivery·2026